Medios AG: Bryan, Garnier & Co initiates coverage of Medios with 'Buy' recommendation and price target of €65.00
DGAP-News: Medios AG / Key word(s): Study/Research Update
Berlin, February 11, 2022 - Bryan, Garnier & Co today initiated coverage of Medios AG and issued a "Buy" recommendation on the shares of the leading provider of Specialty Pharma solutions in Germany. Accordingly, the price target amounts to €65.00 per share. The Medios share price currently stands at €29.45 (Xetra closing on February 10, 2022). In addition to Bryan, Garnier & Co, Medios continues to be covered by Berenberg, Deutsche Bank, Jefferies, Kepler Cheuvreux, Metzler Capital Markets and Warburg.
About Medios AG
Medios AG is the leading provider of Specialty Pharma solutions in Germany. As a competence partner and expert, Medios covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies.
Medios AG is Germany's first listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8) are listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).
|Phone:||+49 30 232 566 - 800|
|Fax:||+49 30 232 566 - 801|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf|
|EQS News ID:||1279764|
|End of News||DGAP News Service|